Distinct Actions of Akt1 and Akt2 in Skeletal Muscle Differentiation

Overview

Journal J Cell Physiol

Specialties Cell Biology
Physiology

Date 2009 Jan 15

PMID 19142853

Citations 37

Authors

Peter Rotwein

Elizabeth M Wilson

Affiliations

Soon will be listed here.

Abstract

Differentiation, maturation, and repair of skeletal muscle requires ongoing cooperation between signaling cascades activated by hormones and growth factors, and intrinsic regulatory programs controlled by myogenic transcription factors. The insulin-like growth factor--phosphatidylinositol-3 kinase--Akt pathway has been implicated in muscle growth and regeneration after injury, in counteracting sarcopenia during aging, and in maintaining muscle cell viability. Here we present evidence for distinct roles for Akt1 and Akt2 in different phases of muscle differentiation. Targeted knockdown of either Akt had no effect on C2 myoblast proliferation, even though Akt1 concentrations are markedly higher than Akt2 levels under growth-promoting conditions. Akt2 concentrations rose by nearly an order of magnitude during muscle differentiation, while Akt1 levels remained constant, yet loss of either protein did not increase myoblast death. Rather, knockdown or genetic knockout of Akt1 blocked differentiation at its earliest stages, preventing induction of muscle-specific proteins and inhibiting formation of multinucleated myofibers, while myoblasts lacking Akt2 differentiated normally, although resultant myofibers were thinner and incorporated fewer nuclei than controls. Forced expression of knockdown-resistant Akt1 partially reversed the deficit in differentiation seen in myoblasts lacking Akt1. Our results define isoform-specific Akt actions in muscle cells, and demonstrate that both Akts are necessary for full myoblast differentiation and maturation.

Citing Articles

Quinine inhibits myogenic differentiation by disrupting AKT signaling pathway.

Byun M, Kim S, Woo R, Noh S, Joo S, Jung Y Toxicol Res. 2025; 41(1):81-90.

PMID: 39802114 PMC: 11717768. DOI: 10.1007/s43188-024-00273-w.

Sca1 Progenitor Cells (Ex vivo) Exhibits Differential Proteomic Signatures From the Culture Adapted Sca1 Cells (In vitro), Both Isolated From Murine Skeletal Muscle Tissue.

Kapoor S, Subba P, P S, Bose B Stem Cell Rev Rep. 2021; 17(5):1754-1767.

PMID: 33742350 DOI: 10.1007/s12015-021-10134-w.

SWELL1 regulates skeletal muscle cell size, intracellular signaling, adiposity and glucose metabolism.

Kumar A, Xie L, Ta C, Hinton A, Gunasekar S, Minerath R Elife. 2020; 9.

PMID: 32930093 PMC: 7541086. DOI: 10.7554/eLife.58941.

Knockdown of Death-Associated Protein Expression Induces Global Transcriptome Changes in Proliferating and Differentiating Muscle Satellite Cells.

Horton K, Sporer K, Tempelman R, Malila Y, Reed K, Velleman S Front Physiol. 2020; 11:1036.

PMID: 32922311 PMC: 7457014. DOI: 10.3389/fphys.2020.01036.

Muscle Atrophy Marker Expression Differs between Rotary Cell Culture System and Animal Studies.

Harding C, Vargis E Biomed Res Int. 2019; 2019:2042808.

PMID: 30906768 PMC: 6398068. DOI: 10.1155/2019/2042808.

References

Heron-Milhavet L, Mamaeva D, Rochat A, Lamb N, Fernandez A . Akt2 is implicated in skeletal muscle differentiation and specifically binds Prohibitin2/REA. J Cell Physiol. 2007; 214(1):158-65. DOI: 10.1002/jcp.21177. View

Rommel C, Bodine S, Clarke B, Rossman R, Nunez L, Stitt T . Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nat Cell Biol. 2001; 3(11):1009-13. DOI: 10.1038/ncb1101-1009. View

Woodgett J . Recent advances in the protein kinase B signaling pathway. Curr Opin Cell Biol. 2005; 17(2):150-7. DOI: 10.1016/j.ceb.2005.02.010. View

Sugatani T, Hruska K . Akt1/Akt2 and mammalian target of rapamycin/Bim play critical roles in osteoclast differentiation and survival, respectively, whereas Akt is dispensable for cell survival in isolated osteoclast precursors. J Biol Chem. 2004; 280(5):3583-9. DOI: 10.1074/jbc.M410480200. View

George S, Rochford J, Wolfrum C, Gray S, Schinner S, Wilson J . A family with severe insulin resistance and diabetes due to a mutation in AKT2. Science. 2004; 304(5675):1325-8. PMC: 2258004. DOI: 10.1126/science.1096706. View

Zhou G, Tucker D, Bae S, Bhatheja K, Birnbaum M, Field J . Opposing roles for Akt1 and Akt2 in Rac/Pak signaling and cell migration. J Biol Chem. 2006; 281(47):36443-53. DOI: 10.1074/jbc.M600788200. View

Heron-Milhavet L, Franckhauser C, Rana V, Berthenet C, Fisher D, Hemmings B . Only Akt1 is required for proliferation, while Akt2 promotes cell cycle exit through p21 binding. Mol Cell Biol. 2006; 26(22):8267-80. PMC: 1636765. DOI: 10.1128/MCB.00201-06. View

Park I, Chen J . Mammalian target of rapamycin (mTOR) signaling is required for a late-stage fusion process during skeletal myotube maturation. J Biol Chem. 2005; 280(36):32009-17. DOI: 10.1074/jbc.M506120200. View

Kaneko S, Feldman R, Yu L, Wu Z, Gritsko T, Shelley S . Positive feedback regulation between Akt2 and MyoD during muscle differentiation. Cloning of Akt2 promoter. J Biol Chem. 2002; 277(26):23230-5. DOI: 10.1074/jbc.M201733200. View

10.

Cho H, Mu J, Kim J, Thorvaldsen J, Chu Q, Crenshaw 3rd E . Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science. 2001; 292(5522):1728-31. DOI: 10.1126/science.292.5522.1728. View

11.

Bouzakri K, Zachrisson A, Al-Khalili L, Zhang B, Koistinen H, Krook A . siRNA-based gene silencing reveals specialized roles of IRS-1/Akt2 and IRS-2/Akt1 in glucose and lipid metabolism in human skeletal muscle. Cell Metab. 2006; 4(1):89-96. DOI: 10.1016/j.cmet.2006.04.008. View

12.

Brazil D, Hemmings B . Ten years of protein kinase B signalling: a hard Akt to follow. Trends Biochem Sci. 2001; 26(11):657-64. DOI: 10.1016/s0968-0004(01)01958-2. View

13.

Thrash B, Menges C, Pierce R, McCance D . AKT1 provides an essential survival signal required for differentiation and stratification of primary human keratinocytes. J Biol Chem. 2006; 281(17):12155-62. DOI: 10.1074/jbc.M512116200. View

14.

Fujio Y, Mitsuuchi Y, Testa J, Walsh K . Activation of Akt2 Inhibits anoikis and apoptosis induced by myogenic differentiation. Cell Death Differ. 2001; 8(12):1207-12. DOI: 10.1038/sj.cdd.4400919. View

15.

Erbay E, Chen J . The mammalian target of rapamycin regulates C2C12 myogenesis via a kinase-independent mechanism. J Biol Chem. 2001; 276(39):36079-82. DOI: 10.1074/jbc.C100406200. View

16.

Hoffman E, Nader G . Balancing muscle hypertrophy and atrophy. Nat Med. 2004; 10(6):584-5. DOI: 10.1038/nm0604-584. View

17.

Cleasby M, Reinten T, Cooney G, James D, Kraegen E . Functional studies of Akt isoform specificity in skeletal muscle in vivo; maintained insulin sensitivity despite reduced insulin receptor substrate-1 expression. Mol Endocrinol. 2006; 21(1):215-28. DOI: 10.1210/me.2006-0154. View

18.

Jansen K, Pavlath G . Mannose receptor regulates myoblast motility and muscle growth. J Cell Biol. 2006; 174(3):403-13. PMC: 2064236. DOI: 10.1083/jcb.200601102. View

19.

Tureckova J, Wilson E, Cappalonga J, Rotwein P . Insulin-like growth factor-mediated muscle differentiation: collaboration between phosphatidylinositol 3-kinase-Akt-signaling pathways and myogenin. J Biol Chem. 2001; 276(42):39264-70. DOI: 10.1074/jbc.M104991200. View

20.

Easton R, Cho H, Roovers K, Shineman D, Mizrahi M, Forman M . Role for Akt3/protein kinase Bgamma in attainment of normal brain size. Mol Cell Biol. 2005; 25(5):1869-78. PMC: 549378. DOI: 10.1128/MCB.25.5.1869-1878.2005. View